Subconjunctival Sirolimus for the Treatment of Autoimmune Active Anterior Uveiti

NCT00876434 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

5

Enrollment

NIH

Sponsor class

Conditions

Anterior Uveitis

Interventions

DRUG: Sirolimus

Sponsor

National Eye Institute (NEI)